TerrAscend Stock (CSE: TER) (OTC: TRSSF) - Investor Dashboard


➔ TerrAscend
CSE Ticker: TER
OTC Ticker: TRSSF
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees: 20
Established: 2014
CEO: Dr. Michael Nashat

TerrAscend – Management Team


Dr. Michael Nashat – President & CEO

Michael Nashat has over 12 years of experience in patient care, quality assurance, medical and regulatory affairs and R&D. Prior to joining TerrAscend, Mr. Nashat was the Executive Director of OnPharm Independent Pharmacy Group, which represents over 300 pharmacies. A former board member of Ontario College of Pharmacists, Canadian Association of Chain Drug Stores and the Ontario Ministry of Health and Long-Term Care’s Pharmacy Council.

Vijay Sappani – Chief Strategy Officer

Vijay Sappani has over 15 years of experience in sales, marketing, physician/patient programs and logistics services for pharmaceutical products listed under Controlled Drugs and Substance Act. Mr. Sappani’s experience in government relations helps TerrAscend navigate the protocols and procedures of regulatory bodies. Mr. Sappani has also held positions with the Minister of Health and Long-Term Care in Ontario, Ontario Ministry of Health and Long Term Care’s Pharmacy Council and Katz Group

Jeffrey Puglisi – Executive VP & Head of Operations

Jeff Puglisi has over 30 years of experience in Capital Markets and co-founded Puglisi & Co., a New York based securities broker-dealer specializing in investment banking, corporate finance, institutional trading and asset management. He also founded Puglisi Capital Partners, LP, a $200 million investment fund focused on equity investments in both public and private companies.

Roland Nimmo CPA, CA – Interim Chief Financial Officer

Roland Nimmo is a seasoned financial professional and has been a trusted advisor to numerous decision-makers in some of Canada’s largest, most prominent corporations. Roland holds a Honours Degree of Economics from Queens University and is a CPA, CA.

Jason Wild – Chairman

Jason Wild is the President and Chief Investment Officer of JW Asset Management, LLC. Mr. Wild received his license as a pharmacist in 1997, and subsequently founded JW Asset Management, LLC in 1998. The firm has a strong history of finding opportunities within the specialty pharmaceutical sector. He is a graduate of the Arnold and Marie Schwartz College of Pharmacy where he received a bachelor’s degree in Pharmacy.

Significant Insider Ownership


Chairman Jason Wild
34.7mm shares (JW Asset Management)

CEO Michael Nashat
4.04mm shares (Star-Pharma Pan-America Inc.)

CSO Vijay Sappani
5.01mm shares (Ela Family Trust)

Basem Hanna
3.96mm shares (Hanna Family Trust)

Canopy Growth
11.3mm shares

Canopy Rivers
11.3mm shares


Visit TerrAscend, Inc.
at www.terrascend.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. TerrAscend, Inc. is a client of NCV Media, LLC. Read our full disclaimer.